Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
CASE REPORT  

 Article Access Statistics
    Viewed401    
    Printed6    
    Emailed0    
    PDF Downloaded48    
    Comments [Add]    

Recommend this journal

Perioperative management of a patient with double orifice mitral valve with supramitral ring with subaortic membrane with ventricular septal defect and severe pulmonary hypertension: Report of a rare case


1 Department of Anaesthesiology and Intensive Care and Cardiothoracic and Vascular Surgery and Cardiology, GB Pant Hospital (GIPMER) and Jaypee Hospital, New Delhi, India
2 Department CTVS, GB pant Hospital (GIPMER), New Delhi, India
3 Department of Cardiology, Jaypee Hospital, New Delhi, India

Correspondence Address:
Vishnu Datt
Department of Anaesthesiology and Intensive Care, Room No. 629, Academic Block, GB Pant Hospital, New Delhi - 110 002
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aca.ACA_123_18

Rights and Permissions

Year : 2019  |  Volume : 22  |  Issue : 2  |  Page : 215-220

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (1,265 KB)
Email article
Print Article
Add to My List
Double-orifice mitral valve (DOMV) is an unusual congenital anomaly characterized by a mitral valve with a single fibrous annulus with two orifices or rarely two orifices with two separate mitral annuli opening into the left ventricle. We present a first report of a patient with a DOMV with supramitral ring (SMR), subaortic membrane (SAM), a large ventricular septal defect (VSD) with more than 50% aortic override, and severe pulmonary arterial hypertrophy (PAH). This patient underwent excision of the SAM, and SMR, with closure of the VSD together under cardiopulmonary bypass (CPB). However postoperatively, the patient developed an irreversible fatal pulmonary hypertensive crisis (PHC), immediately after transferring the patient to the cardiac intensive care unit from the operating room (OR). The PHC was refractory to intravenous and inhaled milrinone and nitroglycerine and intravenous adrenaline, dobutamine, norepinephrine, vasopressin, patent foramen oval (PFO), and CPB support. The management of DOMV and perioperative pulmonary hypertension is discussed.






[FULL TEXT] [PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 CASE REPORT
 




1 Department of Anaesthesiology and Intensive Care and Cardiothoracic and Vascular Surgery and Cardiology, GB Pant Hospital (GIPMER) and Jaypee Hospital, New Delhi, India
2 Department CTVS, GB pant Hospital (GIPMER), New Delhi, India
3 Department of Cardiology, Jaypee Hospital, New Delhi, India

Correspondence Address:
Vishnu Datt
Department of Anaesthesiology and Intensive Care, Room No. 629, Academic Block, GB Pant Hospital, New Delhi - 110 002
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aca.ACA_123_18

Rights and Permissions

Double-orifice mitral valve (DOMV) is an unusual congenital anomaly characterized by a mitral valve with a single fibrous annulus with two orifices or rarely two orifices with two separate mitral annuli opening into the left ventricle. We present a first report of a patient with a DOMV with supramitral ring (SMR), subaortic membrane (SAM), a large ventricular septal defect (VSD) with more than 50% aortic override, and severe pulmonary arterial hypertrophy (PAH). This patient underwent excision of the SAM, and SMR, with closure of the VSD together under cardiopulmonary bypass (CPB). However postoperatively, the patient developed an irreversible fatal pulmonary hypertensive crisis (PHC), immediately after transferring the patient to the cardiac intensive care unit from the operating room (OR). The PHC was refractory to intravenous and inhaled milrinone and nitroglycerine and intravenous adrenaline, dobutamine, norepinephrine, vasopressin, patent foramen oval (PFO), and CPB support. The management of DOMV and perioperative pulmonary hypertension is discussed.






[FULL TEXT] [PDF]*


        
Print this article     Email this article